Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 7, 2006, Pages 733-737

  Basu, Kumar K ^a   Talwar, Vivan ^a   De Caestecker, John S ^a,b  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^b LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Argon plasma coagulation; Barrett's epithelium; Oesophageal motility

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; AGED; ARGON PLASMA COAGULATION; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGUS MANOMETRY; ESOPHAGUS MOTILITY; FEMALE; HUMAN; LOWER ESOPHAGUS SPHINCTER; LOWER ESOPHAGUS SPHINCTER PRESSURE; MALE; PERISTALSIS; PRIORITY JOURNAL; SAFETY; SURGICAL TECHNIQUE; THERMOABLATION; TREATMENT OUTCOME;

ADULT; AGED; ANTACIDS; BARRETT ESOPHAGUS; COMBINED MODALITY THERAPY; ESOPHAGEAL SPHINCTER, LOWER; ESOPHAGUS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; LASER COAGULATION; MALE; MANOMETRY; MIDDLE AGED; PERISTALSIS; POSTOPERATIVE PERIOD; PROTON PUMPS;

EID: 33745263979     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000216928.91618.9a     Document Type: Article

References (45)

1. Spechler SJ, Goyal RK. The columnar lined esophagus, intestinal metaplasia and Norman Barrett. Gastroenterology 1996; 110:614-662.
2. Parrila P, Ortiz A, Martinez de Haro LF, Aguayo JL, Ramirez P. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus. Gut 1990; 31:964-967.
3. Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. Am J Gastroenterol 2001; 96:331-337.
4. Gillen P, Keeling P, Byrne PJ, Hennessy TP. Barrett's oesophagus: pH profile. Br J Surg 1987; 74:774-776.
5. Niemantsverdriet EC, Timmer R, Breumelhof R, Smout AJPM. The roles of excessive gastro-oesophageal reflux, disordered oesophageal motility and decreased mucosal sensitivity in the pathogenesis of Barrett's oesophagus. Eur J Gastroenterol Hepatol 1997; 9:515-519.
6. Zaninotto G, DeMeester TR, Schwizer W, Johansson KE, Cheng SC. The lower esophageal sphincter in health and disease. Am J Surg 1988; 155:104-111.
7. Stein HJ, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 1993; 105:107-111.
8. Basu KK, de Caestecker JS. Surveillance in Barrett's oesophagus: a personal view. Postgrad Med J 2002; 78:263-268.
9. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119:333-338.
10. Jankowski J, Provenzale D, Moayyedi P. Oesophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the West. Gastroenterology 2002; 122:588-590.
11. Sampliner RE. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. Am J Gastroenterol 1994; 89:1844-1848.
12. Neumann CS, Iqbal TH, Cooper BT. Long term continuous omeprazole treatment of patients with Barrett's oesophagus. Aliment Pharmacol Ther 1995; 9:451-454.
13. Sharma P, Sampliner RE, Camargo E. Normalisation of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus. Am J Gastroenterol 1997; 92:582-585.
14. Sagar PM, Ackroyd R, Hosie KB, Patterson JE, Stoddard CJ, Kingsnorth AN. Regression and progression of Barrett's oesophagus after antireflux surgery. Br J Surg 1995; 82:806-810.
15. Ortiz A, Martinez de Haro LF, Parrilla P, Morales G, Molina J, Bermejo J, et al. Conservative treatment versus antireflux surgery in Barrett's oesophagus. Long-term results of a prospective study. Br J Surg 1996; 83:274-278.
16. de Caestecker JS. Endoscopic ablation of Barrett's epithelium. Eur J Gastroenterol Hepatol 1996; 8:619-621.
17. Van Laethem J-L, Cremer M, Peny MO, Delhaye M, Deviere J. Eradication of Barrett's mucosal with argon plasma coagulation and acid suppression: immediate and mid term results. Gut 1998; 43:747-751.
18. Basu KK, Pick B, Bale R, West KP, de Caestecker JS. Efficacy and one year follow-up of argon plasma coagulation therapy for ablation of Barrett's oesophagus: factors determining persistence and recurrence of Barrett's epithelium. Gut 2002; 51:776-780.
19. Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, Blaya C. High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol 2000; 95:1661-1668.
20. Pedrazzani C, Catalano F, Festini M, Zerman G, Tomezzoli A, Ruzzenente A, et al. Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol 2005; 11:1872-1875.
21. McClave SA, Boyce HW, Gottfried MR. Early diagnosis of columnar-lined esophagus: a new endoscopic criterion. Gastrointest Endosc 1987; 33:413-416.
22. Csendes A, Maluenda F, Braghetto I, Csendes P, Henriquez A, Quesada MS. Location of the lower oesophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic oesophagitis. Gut 1993; 34:21-27.
23. Dodd WJ, Hogan WJ, Stef JJ, Miller WN, Lydon SB, Arndorfer RC. A rapid pull-through technique for measuring lower esophageal sphincter pressure. Gastroenterology 1975; 68:437-443.
24. Fox JE, Vidins EI, Beck IT. Observer variation in esophageal pressure assessment. Gastroenterology 1973; 65:884-888.
25. Ask P, Tibbling L. Effect of time interval between swallows on esophageal peristalsis. Am J Physiol 1980; 238:485-490.
26. Richter JE, Wu WC, Johns DN, Blackwell JN, Nelson JL III, Castell JA, Castell DO. Esophageal manometry in 95 healthy adult volunteers: variability of pressures with age and frequency of "abnormal" contractions. Dig Dis Sci 1987; 32:583-592.
27. Fuchs KH, De Meester TR, Albertucci M. Specificity and sensitivity of objective diagnosis of gastro-oesophageal reflux disease. Surgery 1987; 102:575-579.
28. Castell DO. Omeprazole works best when used properly. Eur J Gastroenterol Hepatol 1996; 8:413-414.
29. Mason RJ, Bremner CG. Motility differences between long-segment and short-segment Barrett's esophagus. Am J Surg 1993; 165:686-689.
30. Singh P, Taylor RH, Colin-Jones DG. Esophageal motor dysfunction and acid exposure in reflux esophagitis are more severe if Barrett's metaplasia is present. Am J Gastroenterol 1994; 35:349-356.
31. Marshall JB, Gerhardt DC. Improvement in esophageal motor dysfunction with treatment of reflux esophagitis: a report of two cases. Am J Gastroenterol 1982; 77:351-354.
32. Ortiz A, Martinez de Haro LF, Parrilla PP, Aquayo JL, Garcia MJA, Morales CG. Surgery improves defective oesophageal peristalsis in patients with gastro-oesophageal reflux. Br J Surg 1991; 78:1095-1097.
33. Timmer R, Breumelhof R, Nadorp JHSM, Smout AJPM. Oesophageal motility and gastro-oesophageal reflux before and after healing of reflux oesophagitis: a study using 24-hour ambulatory pH and pressure monitoring. Gut 1994; 35:1519-1522.
34. Howard JM, Reynolds RP, Frei JV, Flowers MA, McDonald TJ, Tilbe K, Bondy DC. Macroscopic healing of esophagitis does not improve esophageal motility. Dig Dis Sci 1994; 39:648-654.
35. Allen ML, McIntosh DL, Robinson MG. Healing or amelioration of esophagitis does not result in increased lower esophageal sphincter or esophageal contractile pressure. Am J Gastroenterol 1990; 85:1331-1334.
36. Rydberg L, Ruth M, Lundell L. Characteristics of secondary oesophageal peristalsis in operated and non-operated patients with chronic gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 2000; 12:739-743.
37. Malhi-Chowla N, Wolfsen HC, DeVault KR. Esophageal dysmotility in patients undergoing photodynamic therapy. Mayo Clin Proc 2001; 76:987-989.
38. Kovacs BJ, Chen YK, Lewis TD, De Guzman LJ, Thompson KS. Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc 1999; 49:547-553.
39. Overholt BF, Panjehpour M. Photodynamic therapy in Barrett's esophagus: reduction of specialised mucosal, ablation of dysplasia and treatment of superficial esophageal cancer. Semin Surg Oncol 1995; 11:372-376.
40. Farin G, Grund KE. Technology of argon plasma coagulation with particular regard to endoscopic applications. Endosc Surg 1994; 2:71-77.
41. Schulz H, Miehlke S, Antos D, Schentke KU, Vieth M, Stolte M, et al. Ablation of Barrett's epithelium by endoscopic argon plasma ablation in combination with high dose omeprazole. Gastrointest Endosc 2000; 51:659-663.
42. Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology 1988; 94:73-80.
43. Tutuian R, Castell DO. Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry. Clin Gastroenterol Hepatol 2004; 2:230-236.
44. Leite LP, Johnston BT, Barrett J, Castell JA, Castell DO. Ineffective esophageal motility (IEM). The primary finding in patients with non-specific esophageal motility disorder. Dig Dis Sci 1997; 42:1859-1865.
45. Chakraborty TK, deCaestecker JS, Pryde A, Heading RC. Effect of omeprazole on lower oesophageal function in normal subjects. Aliment Pharmacol Ther 1987; 1:627-631.